Saengmaeksan inhibits inflammatory mediators by suppressing RIP-2/caspase-1 activation.
Jeong MY, Park DH, Kim MC, Park J, Kim DS, Jeon YD, Kim SJ, Ahn KS, Kim SH, Lee JH, Jung HJ, Hong SH, Um JY.
Jeong MY, et al. Among authors: kim ds, kim sh, kim mc, kim sj.
Immunopharmacol Immunotoxicol. 2013 Apr;35(2):241-50. doi: 10.3109/08923973.2012.757617. Epub 2013 Jan 28.
Immunopharmacol Immunotoxicol. 2013.
PMID: 23356698